Open | $2.450 |
Close | $2.990 |
Volume / Avg. | 2.302M / 102.328K |
Day Range | 2.450 - 3.580 |
52 Wk Range | 1.250 - 2.400 |
Market Cap | $225.927M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 86 |
Short Interest | 2.38% |
Days to Cover | 21.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ChromaDex (NASDAQ: CDXC) through any online brokerage.
Other companies in ChromaDex’s space includes: Harvard Bioscience (NASDAQ:HBIO), CryoPort (NASDAQ:CYRX), Codexis (NASDAQ:CDXS), Mesa Laboratories (NASDAQ:MLAB) and Personalis (NASDAQ:PSNL).
The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 6.00 expecting CDXC to rise to within 12 months (a possible 100.00% upside). 3 analyst firms have reported ratings in the last year.
The stock price for ChromaDex (NASDAQ: CDXC) is $3 last updated March 18, 2024 at 7:54 PM EDT.
There are no upcoming dividends for ChromaDex.
ChromaDex’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for ChromaDex.
ChromaDex is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.